Stock Events

Stock Events

ARS Pharmaceuticals (SPRY) Q3 2025 Earnings

13AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.46

-0.15

0.17

0.48

Details

Expected EPS

-0.45805

Actual EPS

-0.46

Surprise EPS

-0

Surprise Percent

+0.43%

Description

ARS Pharmaceuticals (SPRY) has reported earnings of -0.46 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.